Merck Subsidiary to Market BioServe Biotechnologies Products in India | GenomeWeb
NEW YORK (GenomeWeb News) — Merck Specialties, an Indian subsidiary of Merck, will market and distribute BioServe Biotechnologies’ DNA and RNA purification reagents and DNA sequencing, oligonucleotide synthesis, and molecular biology teaching kits.
 
BioServe said the companies plan to extend the deal throughout Asia later in 2007.
 
BioServe has bases in Hyderabad, India, and in Laurel, Md.
 
Financial terms of the agreement were not released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.